Trial ID or NCT#





The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Official Title

Insulin Resistance Intervention After Stroke (IRIS) Trial

Eligibility Criteria

Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Maarten Lansberg, MD, PhD
Stroke and vascular neurologist, General neurologist
Professor of Neurology at the Stanford University Medical Center
Chitra Venkatasubramanian, MBBS, MD
Neurocritical care specialist, Stroke and vascular neurologist
Clinical Professor, Neurology & Neurological Sciences
Anna Finley Caulfield, MD
Neurocritical care specialist
Clinical Associate Professor, Neurology & Neurological Sciences
Gregory W. Albers, MD
Stroke and vascular neurologist
The Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery at the Stanford University Medical Center

Contact us to find out if this trial is right for you.


Madelleine Garcia
(650) 725-2326